Evaluation of left ventricular systolic function in type 2 diabetes mellitus patients with and without peripheral vascular disease

Table 5 Correlation test in type 2 diabetes mellitus patients with peripheral vascular disease

Varibles	GLSepi		GLSmid		GLSendo		PSD
	r value	P value	r value	P value	r value	P value	r value	P value
BMI	0.089	0.510	0.093	0.491	-0.009	0.945	-0.017	0.900
HbA1c	-0.011	0.935	0.028	0.839	-0.019	0.887	-0.225	0.095
TC	0.190	0.158	0.179	0.182	0.040	0.767	0.293	0.027
TG	-0.126	0.349	-0.153	0.257	-0.148	0.271	0.017	0.889
HDL-C	-0.033	0.812	-0.029	0.834	-0.165	0.228	0.093	0.499
LDL-C	0.340	0.010	0.327	0.014	0.204	0.131	0.290	0.030
LPA	0.159	0.254	0.134	0.339	0.184	0.187	-0.103	0.465
BUN	0.293	0.033	0.248	0.074	0.149	0.287	0.292	0.034
SCR	0.301	0.027	0.264	0.053	0.166	0.231	0.205	0.137
LVEF	-0.434	0.001	-0.439	0.001	-0.447	< 0.001	-0.109	0.420
MAPSE	-0.248	0.063	-0.313	0.018	-0.260	0.051	-0.111	0.411

BMI: Body mass index; HbA1c: Glycated haemoglobin; TC: Total cholesterol; TG: Triglyceride; HDL-C: High density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol; LPA: Lipoprotein a; BUN: Blood urea nitrogen; SCR: Serum creatinine; GLS: Global longitudinal strain; GLSEpi: Global longitudinal strain of the epimyocardial; GLSMid: Global longitudinal strain of the middle myocardial; GLSEndo: Global longitudinal strain of the endomyocardial; PSD: Peak strain dispersion; LVEF: Left ventricular ejection fraction; MAPSE: Mitral annular plane systolic excursion.